Pharmaceutical News

RSS

Researchers analyze the effects of beta-blockers on men and women with hypertension

Women taking beta-blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospitals with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.

13 Jul 2020

New opioid medication may slow the progression of osteoarthritis

A novel preclinical study by Keck Medicine of USC researchers, published in Arthritis & Rheumatology, reveals that a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less addictive than commonly prescribed opioid drugs.

13 Jul 2020

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

U.S. Senators Bill Cassidy (R-La.) and Thomas Carper (D-Del.) are calling on the Centers for Medicare & Medicaid Services to lift regulations that deny insurance coverage for obesity drugs and that limit coverage of Intensive Behavioral Therapy amid the COVID-19 pandemic.

10 Jul 2020

Remdesivir potently inhibits SARS-CoV-2 in human lung cell cultures

The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.

9 Jul 2020

UHN leads first-of-its-kind real world evidence study of medical cannabis

Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of continued opioid use.

9 Jul 2020

CMA levies fines of £2.3m and secures £8m for NHS in pharma probe

The CMA has formally concluded that 3 pharmaceutical companies took part in an illegal arrangement in relation to the supply of life-saving medicine.

9 Jul 2020

Shingles vaccination rate soars but leaves many behind

Worried about the high cost of the copayment for the shingles vaccine, Jacky Felder, a Medicare beneficiary, opted against getting immunized last year.

9 Jul 2020

Facebook allows public to gain stronger voice against the use of HPV vaccine

One of the biggest social media sites -- Facebook -- has allowed "anti-vaxxers" to gain a stronger voice against the use of the human papillomavirus, or HPV, vaccine, according to a new study from a media expert at the University of Missouri.

9 Jul 2020

Analysis: How a COVID-19 vaccine could cost Americans dearly

Yes, of course, Americans' health is priceless, and reining in a deadly virus that has trashed the economy would be invaluable.

8 Jul 2020

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

7 Jul 2020

Study: Hypertension medications can also reduce risk of colorectal cancer

Medications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal.

6 Jul 2020

New NHS guidelines provide instructions on administration of medicines for nurses

The UK's National Health Service (NHS) is changing the way it writes its guidelines for giving injections in hospitals, following groundbreaking research from the University of Bath.

6 Jul 2020

Oxford COVID-19 vaccine trials move to stage 3 human trials

The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.

5 Jul 2020

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

In a recent medRxiv* paper, a research group from the U.S. and Germany showed a robust immunogenic response and a promising safety profile of the novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) – actively encouraging its accelerated clinical development and potential rapid production.

2 Jul 2020

Ceftolozane/tazobactam combo broadens the range of antibiotic therapy, but shows no hint of added benefit

The combination of ceftolozane with tazobactam broadens the range of antibiotic therapy in adults with severe infections of the lungs, the urinary tract, the renal pelvis and the abdominal cavity.

2 Jul 2020

Researchers develop new electronic tool to prevent dangerous polypharmacy

We have an aging population. As the population ages, the prevalence of chronic disease increases. As a result, more and more drugs are prescribed.

2 Jul 2020

Researchers outline checklist for implementing COVID-19 communication strategies

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

2 Jul 2020

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.

2 Jul 2020

Study explores the experiences of patients using hospital-based medicines helpline services

Leaving hospital can be a confusing and sometimes risky time for patients who take medication, with an estimated 44% experiencing medicine-related problems once they get home.

1 Jul 2020

Common asthma drug may offer potential as treatment for Alzheimer's disease

A new study reveals that the common asthma drug salbutamol may offer potential as a treatment for Alzheimer's disease.

1 Jul 2020

Pharmaceutical News

Researchers analyze the effects of beta-blockers on men and women with hypertension

New opioid medication may slow the progression of osteoarthritis

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

Remdesivir potently inhibits SARS-CoV-2 in human lung cell cultures

UHN leads first-of-its-kind real world evidence study of medical cannabis

CMA levies fines of £2.3m and secures £8m for NHS in pharma probe

Shingles vaccination rate soars but leaves many behind

Facebook allows public to gain stronger voice against the use of HPV vaccine

Analysis: How a COVID-19 vaccine could cost Americans dearly

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Study: Hypertension medications can also reduce risk of colorectal cancer

New NHS guidelines provide instructions on administration of medicines for nurses

Oxford COVID-19 vaccine trials move to stage 3 human trials

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

Ceftolozane/tazobactam combo broadens the range of antibiotic therapy, but shows no hint of added benefit

Researchers develop new electronic tool to prevent dangerous polypharmacy

Researchers outline checklist for implementing COVID-19 communication strategies

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

Study explores the experiences of patients using hospital-based medicines helpline services

Common asthma drug may offer potential as treatment for Alzheimer's disease

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Latest News